您的位置: 首页 > 农业专利 > 详情页

COMPOSÉ AYANT UNE ACTIVITÉ AGONISTE DU RÉCEPTEUR DE LA SOMATOSTATINE ET UTILISATION PHARMACEUTIQUE ASSOCIÉE
专利权人:
ONO Pharmaceutical Co.; Ltd.
发明人:
申请号:
EP18751703.2
公开号:
EP3581569A1
申请日:
2018.02.07
申请国别(地区):
EP
年份:
2019
代理人:
摘要:
The present invention provides a somatostatin receptor subtype 2 agonist. The compound disclosed herein represented by the general formula (I):wherein all symbols have the same meanings as the definitions described in the specification;or a salt thereof is a low-molecular compound having strong agonistic activity for somatostatin receptor subtype 2 and can be orally administered. Therefore, the present compound can be easily administered and can alleviate pain accompanied by the therapy of patients. The present compound also has sufficiently weak hERG inhibitory activity and/or phospholipidosis action relative to the SSTR2 agonistic activity, and thus can suppress or alleviate side effects resulting from the activity/action.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充